1998 Jules Gonin lecture of the Retina Research Foundation. Drug treatment of ocular neovascularization and proliferation.
Wiedemann
P
P
D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002448:Cell Adhesion / Q000187:drug effects; D002465:Cell Movement / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D003630:Daunorubicin / Q000627:therapeutic use; D006801:Humans; D000922:Immunotoxins / Q000494:pharmacology; D016023:Integrins / Q000037:antagonists & inhibitors; D015337:Multicenter Studies as Topic; D010456:Peptides, Cyclic / Q000627:therapeutic use; D010857:Pigment Epithelium of Eye / Q000187:drug effects; D015861:Retinal Neovascularization / Q000188:drug therapy*; D014230:Triazoles / Q000627:therapeutic use; D018630:Vitreoretinopathy, Proliferative / Q000188:drug therapy*
D002121:Calcium Channel Blockers; D000922:Immunotoxins; D016023:Integrins; D010456:Peptides, Cyclic; D014230:Triazoles; C092113:cyclo(arginyl-glycyl-aspartyl-phenylalanyl-valyl); C062058:carboxyamido-triazole; D003630:Daunorubicin